Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2010 Jan 01;211:64-72. doi: 10.1681/ASN.2009040406.
Show Gene links
Show Anatomy links
Homozygous SLC2A9 mutations cause severe renal hypouricemia.
Dinour D
,
Gray NK
,
Campbell S
,
Shu X
,
Sawyer L
,
Richardson W
,
Rechavi G
,
Amariglio N
,
Ganon L
,
Sela BA
,
Bahat H
,
Goldman M
,
Weissgarten J
,
Millar MR
,
Wright AF
,
Holtzman EJ
.
???displayArticle.abstract???
Hereditary hypouricemia may result from mutations in the renal tubular uric acid transporter URAT1. Whether mutation of other uric acid transporters produces a similar phenotype is unknown. We studied two families who had severe hereditary hypouricemia and did not have a URAT1 defect. We performed a genome-wide homozygosity screen and linkage analysis and identified the candidate gene SLC2A9, which encodes the glucose transporter 9 (GLUT9). Both families had homozygous SLC2A9 mutations: A missense mutation (L75R) in six affected members of one family and a 36-kb deletion, resulting in a truncated protein, in the other. In vitro, the L75R mutation dramatically impaired transport of uric acid. The mean concentration of serum uric acid of seven homozygous individuals was 0.17 +/- 0.2 mg/dl, and all had a fractional excretion of uric acid >150%. Three individuals had nephrolithiasis, and three had a history of exercise-induced acute renal failure. In conclusion, homozygous loss-of-function mutations of GLUT9 cause a total defect of uric acid absorption, leading to severe renal hypouricemia complicated by nephrolithiasis and exercise-induced acute renal failure. In addition to clarifying renal handling of uric acid, our findings may provide a better understanding of the pathophysiology of acute renal failure, nephrolithiasis, hyperuricemia, and gout.
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008, Pubmed,
Xenbase
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008,
Pubmed
,
Xenbase
Augustin,
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.
2004,
Pubmed
,
Xenbase
Bahat,
Non-urate transporter 1-related renal hypouricemia and acute renal failure in an Israeli-Arab family.
2009,
Pubmed
Bannasch,
Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.
2008,
Pubmed
Caulfield,
SLC2A9 is a high-capacity urate transporter in humans.
2008,
Pubmed
,
Xenbase
Cheong,
Mutational analysis of idiopathic renal hypouricemia in Korea.
2005,
Pubmed
Döring,
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
2008,
Pubmed
Ejaz,
Could uric acid have a role in acute renal failure?
2007,
Pubmed
Enomoto,
Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
2002,
Pubmed
,
Xenbase
Feig,
Uric acid and cardiovascular risk.
2008,
Pubmed
Gray,
Multiple portions of poly(A)-binding protein stimulate translation in vivo.
2000,
Pubmed
,
Xenbase
Hagos,
Human renal organic anion transporter 4 operates as an asymmetric urate transporter.
2007,
Pubmed
,
Xenbase
Ichida,
Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese.
2008,
Pubmed
Ichida,
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion.
2004,
Pubmed
Ishikawa,
Acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise in patients with or without renal hypouricemia.
2002,
Pubmed
Iwai,
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese.
2004,
Pubmed
Kolz,
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.
2009,
Pubmed
Komoda,
The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.
2004,
Pubmed
Li,
The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.
2007,
Pubmed
Matsuo,
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.
2008,
Pubmed
Ohta,
Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan.
2004,
Pubmed
Phay,
Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9).
2000,
Pubmed
Schild,
The ENaC channel as the primary determinant of two human diseases: Liddle syndrome and pseudohypoaldosteronism.
1996,
Pubmed
Sperling,
Hereditary renal hypouricemia.
2006,
Pubmed
Stark,
Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
2008,
Pubmed
Taniguchi,
Control of renal uric acid excretion and gout.
2008,
Pubmed
Uchino,
p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1.
2000,
Pubmed
Vitart,
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
2008,
Pubmed
,
Xenbase
Wakida,
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia.
2005,
Pubmed
,
Xenbase
Waring,
Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers.
2006,
Pubmed
Woodward,
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
2009,
Pubmed
,
Xenbase
Wu,
Urate oxidase: primary structure and evolutionary implications.
1989,
Pubmed
